Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma
Flavia V. Castelino(Harvard University), Andrew M. Tager(Harvard University), Gretchen Bain(University of California San Diego), Andrew D. Luster(Harvard University), James S. Swaney, Jon Seiders, Christopher D. King, Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Daniel S. Lorrain, Sarah F. Brooks(Western University)
Cited by 168
Related Papers
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
|Annual Review of Immunology|2014|2.1k
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
Toll-like receptors stimulate human neutrophil function
|Blood|2003|927
LPA Receptors: Subtypes and Biological Actions
|The Annual Review of Pharmacology and Toxicology|2010|851